SCHEMBL4417307

SCHEMBL4417307

O=Cc1ccc(-c2ccc(Cl)cc2)nc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.54
CYP11B1 P15538 1/20 0.48
KDM1A O60341 1/20 0.45
MAOB P27338 1/20 0.45
KDM4E B2RXH2 5/20 0.44
ALDH1A1 P00352 5/20 0.44
SMN1; SMN2 Q16637 4/20 0.42
MAPT P10636 2/20 0.42
POLB P06746 1/20 0.42
GRM2 Q14416 1/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
CNR2 P34972 1/20 0.40
METAP2 P50579 1/20 0.39
NOTUM Q6P988 1/20 0.39
CYP1A2 P05177 1/20 0.39
MAPK1 P28482 1/20 0.39
HPGD P15428 2/20 0.38
MITF O75030 1/20 0.38
KLF5 Q13887 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16838738 0.89 HSD17B10 (0.54) HSD17B10CYP11B1KDM1AMAOBKDM4E
SCHEMBL28682644 0.88 CYP11B1 (0.56) HSD17B10CYP11B1KDM4EALDH1A1SMN1; SMN2
SCHEMBL30747787 0.88 CYP11B1 (0.56) HSD17B10CYP11B1KDM4EALDH1A1SMN1; SMN2
SCHEMBL13568531 0.81 ALDH5A1 (0.54) HSD17B10CYP11B1KDM1AKDM4EALDH1A1
SCHEMBL30578701 0.81 KDM4E (0.54) CYP11B1KDM1AKDM4EALDH1A1SMN1; SMN2
SCHEMBL2322298 0.81 KDM4E (0.54) CYP11B1KDM1AKDM4EALDH1A1SMN1; SMN2
SCHEMBL13527931 0.81 CYP11B1 (0.48) CYP11B1KDM4EALDH1A1SMN1; SMN2NPC1
SCHEMBL4425760 0.81 ALDH1A1 (0.54) CYP11B1MAOBKDM4EALDH1A1SMN1; SMN2
SCHEMBL9805366 0.81 NPC1 (0.49) CYP11B1MAOBKDM4EALDH1A1SMN1; SMN2
SCHEMBL30382878 0.81 LDHA (0.52) CYP11B1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed
EP-1479671-B1 Pyrimidinone compounds SMITHKLINE BEECHAM PLC (GB) 2009-05-27 EP disclosed
US-7115616-B2 Pyrimidinone compounds SMITHKLINE BEECHAM PLC (GB) 2006-10-03 US disclosed
US-6953803-B1 1-[(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)]-2-(4-fluorobenzyl)thio-5-(1-methyl-4-pyrazolylmethyl)pyrimidin-4-one; enzyme inhibitors of lipoprotein associated phospholipase A2 (Lp-PLA2); atherosclerosis SMITHKLINE BEECHAM P.L.C. (GB) 2005-10-11 US disclosed